The goal of this activity is for learners to be better able to discuss the latest insights and advancements in the management of uncontrolled/resistant hypertension, the specific role of novel therapies, and appropriate application of these therapies in clinical practice to optimize blood pressure (BP) control in patients with uncontrolled/resistant hypertension.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001614
- Start Date: 2024-09-19 05:00:00
- End Date: 2024-09-19 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Idorsia Pharmaceuticals, Ltd. - Amount: 84464.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease, Internal Medicine
Subscribe
Login
0 Comments
Oldest